Amyloid precursor protein proteoglycan is increased after brain damage

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1406, Issue 3, 1998, Pages 237-250

  Salinero, Olga ^a   Garrido, Juan Jose ^a   Wandosell, Francisco ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Alzheimer's disease; Amyloid; Brain damage; Extracellular matrix; Neurotoxicity

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHONDROITIN SULFATE; PROTEOGLYCAN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIBODY SPECIFICITY; BRAIN; IMMUNE SERA; IMMUNOGLOBULIN G; INJECTIONS, INTRAVENTRICULAR; KAINIC ACID; MALE; PEPTIDE FRAGMENTS; PROTEOCHONDROITIN SULFATES; RATS; RATS, WISTAR; STEREOTAXIC TECHNIQUES;

EID: 0031835875     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(98)00009-X     Document Type: Article

References (46)

1. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
2. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82:1985;4245-4249.
3. Kang J., Lemaire H., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K., Multhaup G., Beyreuther K., Müller Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
4. Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., Ito H. Novel precursor of Alzheimer's disease shows protease inhibitor activity. Nature. 311:1988;530-532.
5. Ponte P., Gonzalez-DeWhitt P., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F., Cordell B. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 331:1988;525-527.
6. Tanzi R.E., McClatchey A.I., Lamperti E.D., Villa-Komaroff L., Gusella J.F., Neve R.L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 311:1988;528-530.
7. Anderson J.P., Esch F.S., Keim P.S., Sambamurti K., Lieberburg I., Robakis N.K. Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci. Lett. 12:1991;126-128.
8. Esch F.S., Keim P.S., Beattie E.C., Blacher R.W., Culwell A.R., Oltersdorf T., McClure D., Ward P.J. Cleavage of amyloid beta-peptide during constitutive processing of its precursor. Science. 248:1990;1122-1124.
9. Wang R., Meschia J.F., Cotter R.J., Sisodia S.S. Secretion of Aβ4 amyloid precursor protein. Identification of a cleavage site in mammalian cells. J. Biol. Chem. 266:1991;16960-16964.
10. Oltersdorf T., Fritz L.C., Shenk D.B., Lieberburg I., Johnson-Wood K.L., Beattie E.C., Ward P.J., Blacher R.W., Dovey H.F., Sinha S. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature. 341:1989;144-147.
11. Van Nostrand W.E., Wagner S.L., Suzuki M., Choi B.H., Farrow J.S., Geddes J.W., Cotman C.W., Cunningham D.D. Protease nexin-II, a potent antichymotripsin, shows identity to amyloid β-protein precursor. Nature. 341:1989;546-549.
12. Van Nostrand W.E., Farrow J.F., Wagner S.L., Bhasin R., Goldgaber D., Cotman C.W., Cunningham D.D. The predominant form of the amyloid β-protein precursor in human brain is protease nexin 2. Proc. Natl. Acad. Sci. 88:1991;10302-10306.
13. Selkoe D.J. Normal and abnormal biology of the β amyloid precursor protein. Annu. Rev. Neurosci. 17:1994;489-517.
14. Shoji M., Golde T., Ghiso J., Cheung T., Estus S., Shaffer L., Cai X., McKay D., Tinter R., Frangione B., Youkin S. Production of the Alzheimer β protein by normal proteolytic processing. Science. 258:1992;126-129.
15. Haas C.A., Koo E.H., Mellon A., Hung A.Y., Selkoe D.J. Targeting of cell surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature. 357:1992;500-503.
16. Busciglio J., Gabuzda D.H., Matsudaira P., Yankner B.A. Generation of β-amyloid in the secretory pathway in neuronal and non-neuronal cells. Proc. Natl. Acad. Sci. 90:1993;2092-2096.
17. Lemaire H., Salbaum J.M., Multhaup G., Kang J., Bayney R.M., Unterbeck A., Beyreuther K., Müller-Hill B. The pre-A4 695 precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons. Nucleic Acids Res. 17:1989;517-522.
18. Haas C.A., Selkoe D.J. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell. 75:1993;1039-1042.
19. Weidmann A., Köning G., Bunke D., Fischer P., Salbaum J.M., Masters C.L., Beyreuther K. Identification, biogenesis and localization of precursor of Alzheimer's disease A4 amyloid protein. Cell. 57:1989;115-126.
20. Caporaso G.L., Gandy S.E., Buxbaum J.D., Ramabhadran T.V., Greengard P. Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. 8:1992;3055-3059.
21. Potemska A., Styles J., Mehta P., Kim K.S., Miller D.L. Purification and tissue level of the β-amyloid peptide precursor of rat brain. J. Biol. Chem. 266:1991;8464-8469.
22. Schubert D., Jin L.W., Saitoh T., Cole G. The regulation of amyloid protein precursor secretion and its modulatory role in cell adhesion. Neuron. 3:1989;689-694.
23. Wu A., Pangalos M.N., Efthimiopoulos S., Shioi J., Robakis N. Appican expression induces morphological changes in C6 glioma cells and promote adhesion of neural cells to the extracellular matrix. J. Neurosci. 17-13:1997;4987-4993.
24. Shioi J., Anderson J.P., Ripellino J.A., Robakis N.K. Chondrotin sulfate proteoglycan form of Alzheimer's beta-amyloid precursor. J. Biol. Chem. 267:1992;13819-13822.
25. Shioi J., Refolo L., Efthimiopoulos S., Robakis N.K. Chondroitin sulfate proteoglycan form of cellular and cell-surface Alzheimer amyloid precursor. Neurosci. Lett. 154:1993;121-124.
26. Shioi J., Pangalos M.N., Ripellino J.A., Vassilacopoulou D., Mytilineou C., Margolis R.U., Robakis N.K. The Alzheimer amyloid precursor proteoglycan (appican) is present in brain and is produced by astrocytes but not by neurons in primary neural cultures. J. Biol. Chem. 270:1995;11839-11844.
27. Pangalos M.N., Shioi J., Robakis N.K. Expression of the chondroitin sulfate proteoglycans of amyloid precursor (appican) and amyloid precursor-like protein 2. J. Neurochem. 65:1995;762-769.
28. Pangalos M.N., Efthimiopoulos S., Shioi J., Robakis N.K. The chondroitin sulfate attachment site of appican is formed by splicing out exon 15 of the amyloid precursor protein. J. Biol. Chem. 270:1995;10388-10391.
29. Thinakaran G., Slunt H., Sisodia S.S. Novel regulation of Chondroitin sulfate glycosaminoglycan modification of amyloid precursor protein and its homologue, APLP2. J. Biol. Chem. 270:1995;16522-16525.
30. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
31. M. Araujo, J.J. Garrido, F.G. Wandosell, Differential β-amyloid precursor protein expression after isomorphic and anisomorphic brain damage, 1997, submitted.
32. Bovolenta P., Wandosell F., Nieto-Sampedro M. Characterization of a neurite outgrowth inhibitor expressed after CNS injury. Eur. J. Neurosci. 5:1993;454-465.
33. Gurd J.W., Jones L.R., Mahler H.R., Moore W.J. Isolation and partial characterization of rat brain synaptic plasma membranes. J. Neurochem. 22:1974;281-290.
34. Araujo M., Wandosell F.G. Differential cellular response after glutamate analog hippocampal damage. J. Neurosci. Res. 44:1996;397-408.
35. Wandosell F., Bovolenta P., Nieto-Sampedro M. Differences between reactive astrocytes and cultured astrocytes treated with di-butyryl-cyclic AMP. J. Neuropathol. Exp. Neurol. 52:1993;205-215.
36. E. Harlow, D. Lane, 1988. Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, New York.
37. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
38. Schägger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
39. Herdon M.E., Lander A.D. A diverse set of developmentally regulated proteoglycans is expressed in the rat central nervous system. Neuron. 4:1990;945-961.
40. Slunt H., Thinakaran G., Von Kock C., Lo A., Tanzi R., Sisodia S. Expression of a ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP). J. Biol. Chem. 269:1994;2637-2644.
41. Wasco W., Bupp K., Magedantz M., Gusella J.F., Tanzi R.E., Solomon F. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid β-protein precursor. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10758-10762.
42. Schubert D., La Corbiere M., Saitoh T., Cole G. Characterization of an amyloid precursor protein that binds heparin and contains tyrosine sulfate. Proc. Natl. Acad. Sci. U.S.A. 86:1989;2066-2069.
43. Snow A.D., Kinsella M.G., Prather P.B., Nochlin D., Podlisny M.B., Selkoe D.J., Kisilevsky R., Hassell J., Wight T.N. A characteristic binding affinity between heparan-sulfate proteoglycans and the A4 amyloid protein of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 48:1988;352. (Abstr.).
44. Snow A.D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., Wight T.N. The presence of heparan-sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133:1988;456-463.
45. Snow A.D., Sekiguchi R.T., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreire W., Morgan D.G. An important role of heparan-sulfate proteoglycan (Perlecan) in a model system for deposition and persistence of fibrillar Aβ-amyloid in rat brain. Neuron. 12:1994;219-234.
46. Snow A.D., Mar H., Nochlin D., Sekiguchi R.T., Kimata K., Koike Y., Wight T.N. Early accumulation of heparan-sulfate in neurons and in the Aβ myloid protein containing lesions of Alzheimer's disease and Down syndrome. Am. J. Pathol. 137:1990;1253-1270.